ADA Scientific Sessions 2026 Abstract

Association of GLP-1 Use and End-Stage Liver Disease (ESLD) Events in U.S. Adults with Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD)

Study in peoplePopulations

The paper